We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$869B
AUM Growth
+$32.9B
Cap. Flow
-$6.92B
Cap. Flow %
-0.8%
Top 10 Hldgs %
33.83%
Holding
3,059
New
82
Increased
1,782
Reduced
864
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$2.31B
2
AAPL icon
Apple
AAPL
+$1.58B
3
SHW icon
Sherwin-Williams
SHW
+$1.37B
4
HUBS icon
HubSpot
HUBS
+$1.32B
5
KVUE icon
Kenvue
KVUE
+$1.25B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.37B
2
LRCX icon
Lam Research
LRCX
+$1.54B
3
AMAT icon
Applied Materials
AMAT
+$1.33B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.19B
5
HAL icon
Halliburton
HAL
+$1.16B

Sector Composition

Rank Sector Weight
1 Technology 32.32%
2 Healthcare 15.15%
3 Financials 10.54%
4 Consumer Discretionary 10.48%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVO icon
2976
LiveOne
LVO
$55.1M
$21K ﹤0.01%
2,205
OVID icon
2977
Ovid Therapeutics
OVID
$496M
$21K ﹤0.01%
17,396
ALXO icon
2978
ALX Oncology
ALXO
$274M
$20K ﹤0.01%
10,622
DRRX
2979
DELISTED
DURECT Corp
DRRX
$20K ﹤0.01%
14,210
SST icon
2980
System1
SST
$19.7M
$20K ﹤0.01%
1,760
MOND
2981
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$20K ﹤0.01%
13,767
-2,774
-17% -$5.87K
WGSWW
2982
DELISTED
GeneDx Holdings Warrant
WGSWW
$19K ﹤0.01%
250,930
GOEV
2983
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$19K ﹤0.01%
961
HLVX
2984
DELISTED
HilleVax
HLVX
$18K ﹤0.01%
10,063
SBDS
2985
DELISTED
Solo Brands Inc
SBDS
$18K ﹤0.01%
+302
New +$21.5K
STIM icon
2986
Neuronetics
STIM
$229M
$15K ﹤0.01%
19,100
LLAP
2987
DELISTED
Terran Orbital Corporation
LLAP
$13K ﹤0.01%
49,970
AQMS icon
2988
Aqua Metals
AQMS
$9.78M
$12K ﹤0.01%
299
ELEV
2989
DELISTED
Elevation Oncology
ELEV
$11K ﹤0.01%
16,841
MKTW icon
2990
MarketWise
MKTW
$54.6M
$11K ﹤0.01%
+802
New +$14.7K
LNAI
2991
Lunai Bioworks
LNAI
$10.2M
$8K ﹤0.01%
199
LYRA
2992
DELISTED
LYRA THERAPEUTICS INC
LYRA
$5K ﹤0.01%
351
GCTS.WS
2993
GCT Semiconductor Holding Warrants
GCTS.WS
$20.6M
$5K ﹤0.01%
37,675
VSTEW
2994
DELISTED
Vast Renewables Limited Warrants
VSTEW
$2K ﹤0.01%
38,375
RCFA.WS
2995
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$2K ﹤0.01%
37,850
SRZNW
2996
DELISTED
Surrozen Inc Warrant
SRZNW
$1K ﹤0.01%
+41,666
New +$587
BFAC.WS
2997
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$1K ﹤0.01%
55,855
ONYXW
2998
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1K ﹤0.01%
37,750
ALLK
2999
DELISTED
Allakos
ALLK
-620,457
Closed -$621K
AMRN
3000
Amarin Corp
AMRN
$296M
-4,387
Closed -$60K

Similar funds

T. Rowe Price Associates's Q3 2024 Portfolio in Review

As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
  • T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
  • T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
  • T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.

Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.